Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4-Reference-Cited by-同舟云学术

Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4

Published:2014-10-16 Issue:11 Volume:27 Page:1403-1412
ISSN:0952-3480
Container-title:NMR in Biomedicine
language:en
Short-container-title:NMR Biomed.

Author:

Fruytier A.-C.¹,Magat J.¹,Neveu M.-A.¹,Karroum O.¹,Bouzin C.²,Feron O.²,Jordan B.¹,Cron G. O.³⁴,Gallez B.¹

Affiliation:

1. Biomedical Magnetic Resonance Research Group, Louvain Drug Research Institute; Université catholique de Louvain; Brussels Belgium

2. Institut de Recherche Expérimentale et Clinique, Pole of Pharmacology, Angiogenesis and Cancer Research Laboratory; Université catholique de Louvain; Brussels Belgium

3. Ottawa Hospital Research Institute; Ottawa Canada

4. University of Ottawa Faculty of Medicine; Ottawa Canada

Publisher

Wiley

Subject

Spectroscopy,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference55 articles.

1. Multiparametric imaging of tumor response to therapy;Padhani;Radiology,2010

2. Perfusion MRI in the early clinical development of antivascular drugs: decorations or decision making tools?;Zweifel;Eur. J. Nucl. Med. Mol. Imaging,2010

3. Reliability of pharmacokinetic parameters: small vs. medium-sized contrast agents;Jaspers;Magn. Reson. Med.,2009

4. Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies;O'Connor;Nat. Rev. Clin. Oncol.,2012

5. Disrupting tumour blood vessels;Tozer;Nat. Rev. Cancer,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic Contrast-Enhanced MRI Assessing Antifibrotic Therapeutic Effects of Pancreatic Fibrosis with Curcumin – An Experimental Study at 11.7 T;Academic Radiology;2023-09

2. Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression”;Cancers;2023-03-22

3. Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors;Molecules;2021-04-27

4. Impact of myo -inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models;Journal of Cellular and Molecular Medicine;2018-12-21

5. Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology;British Journal of Cancer;2017-09-14